National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 08/20/2008



Purpose of This PDQ Summary






Overview






Etiopathogenesis






Oral and Dental Management Prior to Cancer Therapy






Management Following Cancer Therapy






Oral Mucositis






Infection






Hemorrhage






Neurotoxicity






Graft-versus-Host Disease






Posttransplantation Dental Treatment






Relapse and Second Malignancy






Oral Toxicities Not Related to Chemotherapy or Radiation Therapy






Head/Neck Radiation Patients






Conditions Affected By Both Chemotherapy and Head/Neck Radiation






Psychosocial Issues






Special Considerations in Pediatric Populations






Get More Information From NCI






Changes to This Summary (08/20/2008)






Questions or Comments About This Summary






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Psychosocial Issues

Oral complications of cancer, including oral mucositis,[1] are among the most devastating of both short- and long-term problems encountered by people with cancer because they affect eating and communication, the most basic of human activities. Patients with these problems can become withdrawn, socially avoidant, and even clinically depressed as a result of the difficulties and frustrations they encounter living with oral complications. When employing psychotropic drug interventions in treatment of such patients, it is important to choose them with an eye toward improving or at least not worsening their oral complications. For example, in the treatment of depression in such patients, highly anticholinergic drugs should be avoided in patients with xerostomia and salivary problems. (Refer to the PDQ summaries on Anxiety Disorder and Depression for more information.)

Supportive care including education and symptom management are important for patients experiencing oral complications related to cancer therapy. It is important to closely monitor each patient’s level of distress, ability to cope, and response to treatment. This approach provides a setting for the health professional to demonstrate concern for the patient’s complications and to educate the patient and family caregivers. Comprehensive supportive care from staff and family can enhance the patient’s ability to cope with cancer and its complications.

References

  1. Dodd MJ, Dibble S, Miaskowski C, et al.: A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. J Pain Symptom Manage 21 (6): 498-505, 2001.  [PUBMED Abstract]

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov